MESO Stock Analysis: Buy, Sell, or Hold?
MESO - Mesoblast Limited American Depositary Shares
$16.50
-0.26 (-1.55%)
âŧ
5d:
-4.01%
30d:
+14.03%
90d:
+13.64%
WAIT
LOW Confidence
Analysis Updated: Sep 1, 2026 12:00 AM ET
Earnings: Sep 04, 2026
1d
Get Alerted When MESO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MESO is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MESO is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: MESO is currently trading at $16.50, which is considered fair relative to its 30-day fair value range of $14.93 to $17.23. From a valuation perspective, the stock is trading at a discount (Forward PE: -275.0) compared to its historical average (206.7). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MESO is in a uptrend. The price is currently testing key support at $16.44. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MESO scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $37.00 (+124.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MESO is in a uptrend. The price is currently testing key support at $16.44. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MESO scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $37.00 (+124.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$14.93 -
$17.23
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
54.8%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (39/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 124.2% below Wall St target ($37.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 42/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$14.93 -
$17.23
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$16.44
Resistance Level
$18.33
Current Trend
Uptrend
Technical data as of
Sep 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-275.00
Wall Street Target
$37.00
(+124.2%)
Revenue Growth (YoY)
390.7%
Profit Margin
-47.8%
PE vs Historical
-275.0 vs 206.7
CHEAP
Share & Embed Analysis
Last updated: September 01, 2026 8:19 PM ET
Data refreshes hourly during market hours. Next update: 9:19 PM
Data refreshes hourly during market hours. Next update: 9:19 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MESO showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Gregory George
BUY
2324072 shares
2026-04-10
Gregory George
BUY
1586890 shares
2026-04-09
Gregory George
BUY
1981890 shares
2026-04-09
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 44 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$127 | 51 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$138 | 66 BUY |
|
RNA
Atrium Therapeutics, IncâĻ |
STRONG BUY
15 analysts |
$25 | 38 SELL |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$37 | 43 HOLD |
